UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000014250
Receipt No. R000016600
Public title evaluation of CNS in muscular dystrophy
Date of disclosure of the study information 2014/06/12
Last modified on 2019/03/12 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title evaluation of CNS in muscular dystrophy
Acronym evaluation of CNS in muscular dystrophy
Scientific Title evaluation of CNS in muscular dystrophy
Scientific Title:Acronym evaluation of CNS in muscular dystrophy
Region
Japan

Condition
Condition Muscle dystrophy
Classification by specialty
Neurology Pediatrics Radiology
Laboratory medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 A morphological and functional evaluation of the central nerve of patients with muscular dystrophy
Basic objectives2 Others
Basic objectives -Others Confirmation of the abnormal distribution of the GABA receptor using iomazenil SPECT
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes We confirm a function and morphological abnormal presence
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Other
Interventions/Control_1 Iomazenile SPECT/MRI/PET/EEG/clinical examination
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
50 years-old >=
Gender Male
Key inclusion criteria The patients with muscular dystrophy
Key exclusion criteria The person that an examination for 30-minute imaging is impossible

exclude the patients who are recognized as inadequate patients by doctors with responsibility in this study
Target sample size 30

Research contact person
Last name of lead principal investigator
1st name Tsutomu
Middle name
Last name Nakada
Organization University of Niigata,
Brain Research Institute
Division name Center for Integrated Human Brain Science
Zip code 951-8585
Address Asahimachi 1-757, Chuo-ku,Niigata
TEL 025-227-0683
Email tnakada@bri.niigata-u.ac.jp

Public contact
1st name of contact person
1st name Yuji
Middle name
Last name Suzuki
Organization University of Niigata, Brain Research Institute
Division name Center for Integrated Human Brain Science
Zip code 951-8585
Address Asahimachi 1-757, Chuo-ku,Niigata
TEL 025-227-0683
Homepage URL
Email yuji-s@bri.niigata-u.ac.jp

Sponsor
Institute Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata
Institute
Department

Funding Source
Organization grant from Ministry of Education, Culture, Sports, Science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor National Hospital Organization, Niigata National Hospital
Name of secondary funder(s)

IRB Contact (For public release)
Organization Niigata National Hospital
Address 3-52 Akasaka-cho Kashiwazaki, Niigata
Tel 0257-22-2126
Email 225sy01@hosp.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 国立病院機構新潟病院

Other administrative information
Date of disclosure of the study information
2014 Year 06 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 02 Month 17 Day
Date of IRB
2012 Year 01 Month 30 Day
Anticipated trial start date
2012 Year 03 Month 01 Day
Last follow-up date
2019 Year 01 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2014 Year 06 Month 12 Day
Last modified on
2019 Year 03 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016600